D-Dimer as Biomarker for Prognosis of Coronary Artery Disease and Heart Failure: Reappraisal of Its Central Role

2.

Morange

PE

,

Bickel

C

,

Nicaud

V

,

Schnabel

R

,

Rupprecht

HJ

,

Peetz

D

, et al.

Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

.

Arterioscler Thromb Vasc Biol

.

2006

;

26

(

12

):

2793

–

9

.

3.

Folsom

AR

,

Delaney

JAC

,

Lutsey

PL

,

Zakai

NA

,

Jenny

NS

,

Polak

JF

, et al.

Associations of factor VIII c, D‐dimer, and plasmin–antiplasmin with incident cardiovascular disease and all‐cause mortality

.

Am J Hematol

.

2009

;

84

(

6

):

349

–

53

.

4.

Shaw

E

,

Massaro

J

,

Levy

D

,

O’Donnell

C

,

D’Agostino

R

,

Tofler

G

.

D-Dimer and the risk of cardiovascular disease: the Framingham Heart Study

.

Heart Lung Circ

.

2011

;

20

:

S30

.

5.

Di Castelnuovo

A

,

de Curtis

A

,

Costanzo

S

,

Persichillo

M

,

Olivieri

M

,

Zito

F

, et al.

Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study

.

Haematologica

.

2013

;

98

(

9

):

1476

–

80

.

6.

Auditeau

C

,

Khider

L

,

Planquette

B

,

Sanchez

O

,

Smadja

DM

,

Gendron

N

.

D-dimer testing in clinical practice in the era of COVID-19

.

Res Pract Thromb Haemost

.

2022

;

6

(

4

):

e12730

.

7.

Hayıroğlu

Mİ

,

Çınar

T

,

Tekkeşin

Aİ

.

Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review

.

Rev Assoc Med Bras

.

2020

;

66

(

6

):

842

–

8

.

8.

Connors

JM

,

Levy

JH

.

COVID-19 and its implications for thrombosis and anticoagulation

.

Blood

.

2020

;

135

(

23

):

2033

–

40

.

9.

Simes

J

,

Robledo

KP

,

White

HD

,

Espinoza

D

,

Stewart

RA

,

Sullivan

DR

, et al.

D-dimer predicts long-term cause-specific mortality, cardiovascular events, and cancer in patients with stable coronary heart disease: LIPID study

.

Circulation

.

2018

;

138

(

7

):

712

–

23

.

10.

Zhang

H

,

Yao

J

,

Huang

Z

,

Zhao

Z

,

Wang

B

,

Zhao

J

.

Prognostic value of baseline D-dimer level in patients with coronary artery disease: a meta-analysis

.

Angiology

.

2022

;

73

(

1

):

18

–

25

.

11.

Naruse

H

,

Ishii

J

,

Takahashi

H

,

Kitagawa

F

,

Okuyama

R

,

Kawai

H

, et al.

Prognostic value of combination of plasma D-dimer concentration and estimated glomerular filtration rate in predicting long-term mortality of patients with stable coronary artery disease

.

Circ J

.

2017

;

81

(

10

):

1506

–

13

.

12.

Chen

R

,

Liu

C

,

Zhou

P

,

Tan

Y

,

Sheng

Z

,

Li

J

, et al.

Prognostic value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study

.

Thromb J

.

2021

;

19

(

1

):

30

.

13.

Lowe

GDO

,

Rumley

A

,

McMahon

AD

,

Ford

I

,

O'Reilly

DSJ

,

Packard

CJ

, et al.

Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease

.

Arterioscler Thromb Vasc Biol

.

2004

;

24

(

8

):

1529

–

34

.

14.

Danesh

J

,

Whincup

P

,

Walker

M

,

Lennon

L

,

Thomson

A

,

Appleby

P

, et al.

Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis

.

Circulation

.

2001

;

103

(

19

):

2323

–

7

.

15.

Satilmisoglu

MH

,

Ozyilmaz

SO

,

Gul

M

,

Ak Yildirim

H

,

Kayapinar

O

,

Gokturk

K

, et al.

Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction

.

Ther Clin Risk Manag

.

2017

;

13

:

393

–

400

.

16.

Yu

T

,

Jiao

Y

,

Song

J

,

He

D

,

Wu

J

,

Sun

Z

, et al.

Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study

.

BMC Cardiovasc Disord

.

2019

;

19

(

1

):

252

.

17.

Sarli

B

,

Akpek

M

,

Baktir

AO

,

Sahin

O

,

Saglam

H

,

Arinc

H

, et al.

Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction

.

Herz

.

2015

;

40

(

3

):

507

–

13

.

18.

Kikkert

WJ

,

Claessen

BE

,

Stone

GW

,

Mehran

R

,

Witzenbichler

B

,

Brodie

BR

, et al.

D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy

.

J Thromb Thrombolysis

.

2014

;

37

(

2

):

155

–

64

.

19.

Akgul

O

,

Uyarel

H

,

Pusuroglu

H

,

Gul

M

,

Isiksacan

N

,

Turen

S

, et al.

Predictive value of elevated D-dimer in patients undergoing primary angioplasty for ST elevation myocardial infarction

.

Blood Coagul Fibrinolysis

.

2013

;

24

(

7

):

704

–

10

.

20.

Kurosawa

Y

,

Shimizu

T

,

Ando

T

,

Akama

J

,

Muto

Y

,

Kimishima

Y

, et al.

The prognostic impact of D-dimer on long-term mortality in patients with coronary artery disease after percutaneous coronary intervention

.

Int Heart J

.

2022

;

63

(

6

):

1070

–

7

.

21.

Lu

P-J

,

Gong

X

,

Liu

Y

,

Tian

F-S

,

Zhang

W-J

,

Liu

Y-W

, et al.

Optimization of GRACE risk stratification by N-Terminal pro-B-type natriuretic peptide combined with D-dimer in patients with Non-ST-elevation myocardial infarction

.

Am J Cardiol

.

2021

;

140

:

13

–

9

.

22.

Huang

D

,

Gao

W

,

Wu

R

,

Zhong

X

,

Qian

J

,

Ge

J

.

D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction

.

Int J Cardiol

.

2020

;

305

:

1

–

4

.

23.

Zhao

X

,

Li

J

,

Tang

X

,

Jiang

L

,

Chen

J

,

Qiao

S

, et al.

D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention

.

Ther Adv Chronic Dis

.

2020

;

11

:

2040622320904302

.

24.

Erkol

A

,

Oduncu

V

,

Turan

B

,

Kılıçgedik

A

,

Sırma

D

,

Gözübüyük

G

, et al.

The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction

.

J Thromb Thrombolysis

.

2014

;

38

(

3

):

339

–

47

.

25.

Zhang

H

,

Qiu

B

,

Zhang

Y

,

Cao

Y

,

Zhang

X

,

Wu

Z

, et al.

The value of pre-infarction angina and plasma D-dimer in predicting no-reflow after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction patients

.

Med Sci Monit

.

2018

;

24

:

4528

–

35

.

26.

Gong

X

,

Lei

X

,

Huang

Z

,

Song

Y

,

Wang

Q

,

Qian

J

, et al.

D-Dimer level predicts angiographic no-Reflow phenomenon after percutaneous coronary intervention within 2–7 days of symptom onset in patients with ST-segment elevation myocardial infarction

.

J Cardiovasc Transl Res

.

2021

;

14

(

4

):

728

–

34

.

27.

Zorlu

A

,

Yilmaz

MB

,

Yucel

H

,

Bektasoglu

G

,

Refiker Ege

M

,

Tandogan

I

.

Increased D-dimer levels predict cardiovascular mortality in patients with systolic heart failure

.

J Thromb Thrombolysis

.

2012

;

33

(

4

):

322

–

8

.

28.

Dahlström

U

,

Lindahl

T

,

Alehagen

U

.

Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure

.

Thromb Haemost

.

2004

;

92

(

12

):

1250

–

8

.

29.

Yan

W

,

Liu

J

,

Liu

H

,

Lu

J

,

Chen

J

,

Rong

R

, et al.

Elevated D-dimer levels predict adverse outcomes in hospitalised elderly patients with chronic heart failure

.

Intern Med J

.

2019

;

49

(

10

):

1299

–

306

.

30.

Huang

B

,

Li

Y-J

,

Shen

J

,

Yang

Y

,

Liu

G

,

Luo

S-X

.

D-dimer level and long-term outcome in patients with end-stage heart failure secondary to idiopathic dilated cardiomyopathy

.

J Geriatr Cardiol

.

2019

;

16

(

8

):

621

–

9

.

31.

Minami

Y

,

Haruki

S

,

Jujo

K

,

Itani

R

,

Shimazaki

K

,

Arashi

H

, et al.

Elevated D-dimer levels predict an adverse outcome in hospitalized patients with acute decompensated heart failure

.

Int J Cardiol

.

2016

;

204

:

42

–

4

.

32.

Huang

Y

,

Zhou

W-W

,

Li

Y-X

,

Chen

X-Z

,

Gui

C

.

The use of D-dimer in the diagnosis and risk assessment of intracardiac thrombus among patients with dilated cardiomyopathy

.

Sci Rep

.

2023

;

13

(

1

):

18075

.

33.

Çinier

G

,

Hayıroğlu

Mİ

,

Kolak

Z

,

Tezen

O

,

Yumurtaş

AÇ

,

Pay

L

, et al.

The value of C‐reactive protein‐to‐albumin ratio in predicting long‐term mortality among HFrEF patients with implantable cardiac defibrillators

.

Eur J Clin Invest

.

2021

;

51

(

8

):

e13550

.

34.

Kalenderoglu

K

,

Hayiroglu

MI

,

Cinar

T

,

Oz

M

,

Bayraktar

GA

,

Cam

R

, et al.

Comparison of inflammatory markers for the prediction of atrial fibrillation recurrence following cryoablation

.

Biomark Med

.

2024

;

18

(

17–18

):

717

–

25

.

35.

Tang

N

,

Li

D

,

Wang

X

,

Sun

Z

.

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

.

J Thromb Haemost

.

2020

;

18

(

4

):

844

–

7

.

36.

Conway

EM

,

Mackman

N

,

Warren

RQ

,

Wolberg

AS

,

Mosnier

LO

,

Campbell

RA

, et al.

Understanding COVID-19-associated coagulopathy

.

Nat Rev Immunol

.

2022

;

22

(

10

):

639

–

49

.

37.

Anghel

L

,

Tudurachi

B

,

Leonte

A

,

Sascău

RA

,

Zota

IM

,

Bazyani

A

, et al.

The challenge of high coronary thrombotic events in patients with ST-segment elevation myocardial infarction and COVID-19

.

J Clin Med

.

2022

;

11

(

21

):

6542

.

38.

Matsushita

K

,

Hess

S

,

Marchandot

B

,

Sato

C

,

Truong

DP

,

Kim

NT

, et al.

Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic

.

J Thromb Thrombolysis

.

2021

;

52

(

1

):

95

–

104

.

39.

Bhatt

AS

,

Daniels

LB

,

de Lemos

J

,

Goodrich

E

,

Bohula

EA

,

Morrow

DA

, et al.

Multi-marker risk assessment in patients hospitalized with COVID-19: results from the American heart association COVID-19 cardiovascular disease registry

.

Am Heart J

.

2023

;

258

:

149

–

56

.

40.

Machowski

M

,

Ou-Pokrzewińska

A

,

Perzanowska-Brzeszkiewicz

K

,

Gałecka-Nowak

M

,

Pacho

S

,

Jermakow

M

, et al.

Predicting acute cardiovascular complications in COVID-19: insights from a specialized cardiac referral department

.

Med Sci Monit

.

2024

;

30

:

e942612

.

41.

AlKhalfan

F

,

Kerneis

M

,

Nafee

T

,

Yee

MK

,

Chi

G

,

Plotnikov

A

, et al.

D-Dimer levels and effect of rivaroxaban on those levels and outcomes in patients with acute coronary syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)

.

Am J Cardiol

.

2018

;

122

(

9

):

1459

–

64

.

42.

Corban

MT

,

Hung

OY

,

Mekonnen

G

,

Eshtehardi

P

,

Eapen

DJ

,

Rasoul-Arzrumly

E

, et al.

Elevated levels of serum fibrin and fibrinogen degradation products are independent predictors of larger coronary plaques and greater plaque necrotic core

.

Circ J

.

2016

;

80

(

4

):

931

–

7

.

43.

Stone

GW

,

Maehara

A

,

Lansky

AJ

,

de Bruyne

B

,

Cristea

E

,

Mintz

GS

, et al.

A prospective natural-history study of coronary atherosclerosis

.

N Eng J Med

.

2011

;

364

(

3

):

226

–

35

.

44.

Criqui

MH

,

Denenberg

JO

,

Ix

JH

,

McClelland

RL

,

Wassel

CL

,

Rifkin

DE

, et al.

Calcium density of coronary artery plaque and risk of incident cardiovascular events

.

JAMA

.

2014

;

311

(

3

):

271

–

8

.

45.

Sato

C

,

Wakabayashi

K

,

Nishikura

T

,

Kobayashi

N

,

Kondo

S

,

Sugiyama

T

, et al.

Predictive value of D-dimer for plaque rupture, thrombus and worse clinical outcomes in acute coronary syndrome from TACTICS registry

.

Eur Heart J

.

2023

;

44

(

Suppl ment_2

):

3599

–

762

.

46.

Kothari

H

,

Nguyen

AT

,

Yang

X

,

Hisada

Y

,

Tsimikas

S

,

Mackman

N

, et al.

Association of D-dimer with plaque characteristics and plasma biomarkers of oxidation-specific epitopes in stable subjects with coronary artery disease

.

J Cardiovasc Transl Res

.

2018

;

11

(

3

):

221

–

9

.

47.

Undas

A

,

Szułdrzynski

K

,

Stepien

E

,

Zalewski

J

,

Godlewski

J

,

Tracz

W

, et al.

Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress

.

Atherosclerosis

.

2008

;

196

(

2

):

551

–

7

.

48.

Choi

S

,

Jang

WJ

,

Song

YB

,

Lima

JAC

,

Guallar

E

,

Choe

YH

, et al.

D-Dimer levels predict myocardial injury in ST-segment elevation myocardial infarction: a cardiac magnetic resonance imaging study

.

PLoS One

.

2016

;

11

(

8

):

e0160955

.

49.

Kumar

R

,

Khan

KA

,

Shah

JA

,

Ammar

A

,

Kumar

D

,

Khowaja

S

, et al.

Quantification of thrombus burden as an independent predictor of intra-procedural no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary revascularization

.

J Ayub Med Coll Abbottabad

.

2022

;

34

(

2

):

288

–

94

.

50.

Sambola

A

,

García Del Blanco

B

,

Ruiz-Meana

M

,

Francisco

J

,

Barrabés

JA

,

Figueras

J

, et al.

Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy

.

Thromb Haemost

.

2016

;

115

(

6

):

1129

–

37

.

51.

Zhou

J

,

Tan

Y

,

Liu

C

,

Zhou

P

,

Sheng

Z

,

Li

J

, et al.

Ticagrelor versus clopidogrel in patients with late or very late stent thrombosis

.

Cardiovasc Drugs Ther

.

2020

;

34

(

5

):

677

–

84

.

52.

Menown

IBA

,

Mathew

TP

,

Gracey

HM

,

Nesbitt

GS

,

Murray

P

,

Young

IS

, et al.

Prediction of recurrent events by D-dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT) study

.

Am Heart J

.

2003

;

145

(

6

):

986

–

92

.

53.

Schepp

M

,

Freuer

D

,

Peters

A

,

Heier

M

,

Teupser

D

,

Meisinger

C

, et al.

Is the habitual dietary intake of foods of plant or animal origin associated with circulating hemostatic factors? results of the population-based KORA-Fit study

.

Nutrients

.

2024

;

16

(

3

):

432

.

54.

Thachil

J

,

Longstaff

C

,

Favaloro

EJ

,

Lippi

G

,

Urano

T

,

Kim

PY

, et al.

The need for accurate D‐dimer reporting in COVID‐19: communication from the ISTH SSC on fibrinolysis

.

J Thromb Haemost

.

2020

;

18

(

9

):

2408

–

11

.

55.

Yu

H-H

,

Qin

C

,

Chen

M

,

Wang

W

,

Tian

D-S

.

D-dimer level is associated with the severity of COVID-19

.

Thromb Res

.

2020

;

195

:

219

–

25

.

56.

Iba

T

,

Wada

H

,

Levy

JH

.

Platelet activation and thrombosis in COVID-19

.

Semin Thromb Hemost

.

2023

;

49

(

01

):

055

–

61

.

57.

Ibañez

C

,

Perdomo

J

,

Calvo

A

,

Ferrando

C

,

Reverter

JC

,

Tassies

D

, et al.

High D-dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there

.

J Thromb Thrombolysis

.

2021

;

51

(

2

):

308

–

12

.

58.

Peyvandi

F

,

Scalambrino

E

,

Clerici

M

,

Lecchi

A

,

Revelli

N

,

Palla

R

, et al.

No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-CoV-2

.

Thromb Update

.

2021

;

4

:

100059

.

59.

Klok

FA

,

Pai

M

,

Huisman

MV

,

Makris

M

.

Vaccine-induced immune thrombotic thrombocytopenia

.

Lancet Haematol

.

2022

;

9

(

1

):

e73

–

80

.

60.

Hippisley-Cox

J

,

Patone

M

,

Mei

XW

,

Saatci

D

,

Dixon

S

,

Khunti

K

, et al.

Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

.

BMJ

.

2021

;

374

:

n1931

.

61.

Franchini

M

,

Focosi

D

,

Pezzo

MP

,

Mannucci

PM

.

How we manage a high D-dimer

.

Haematol

.

2023

;

104

:

1035

–

45

.

62.

Li

J

,

Zhu

P

,

Tang

X

,

Jiang

L

,

Li

Y

,

Yan

K

, et al.

Combined effect of D-dimer, hs-CRP, and Lp(a) on 5-year clinical outcomes after percutaneous coronary intervention: a large real-world study in China

.

iScience

.

2023

;

26

(

7

):

107030

.

63.

Zhang

Z-L

,

Li

R

,

Yang

F-Y

,

Xi

L

.

Natriuretic peptide family as diagnostic/prognostic biomarker and treatment modality in management of adult and geriatric patients with heart failure: remaining issues and challenges

.

J Geriatr Cardiol

.

2018

;

15

(

8

):

540

–

6

.

64.

Bai

Y

,

Zheng

Y-Y

,

Tang

J-N

,

Yang

X-M

,

Guo

Q-Q

,

Zhang

J-C

, et al.

D-Dimer to fibrinogen ratio as a novel prognostic marker in patients after undergoing percutaneous coronary intervention: a retrospective cohort study

.

Clin Appl Thromb Hemost

.

2020

;

26

:

1076029620948586

.